CLINICAL_TRIALS
trial_result
· 2020-12-28
Clinical Trial Update: A Study of Actonel for the Prevention of Bone Loss [Phase 3]
Summary
Phase 3 trial update for Actonel investigating bone loss prevention; the study completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2020-12-28